Insider Stock Trading History of Narachi Michael


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Narachi Michael since year 2005. The trader's CIK number is 1380022. At the time of this reporting, Narachi Michael is the President and CEO of Orexigen Therapeutics, Inc. . (stock ticker symbol OREX). See this page for all insider trading activities at Orexigen Therapeutics, Inc. .

Note that in the past NARACHI MICHAEL also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Narachi Michael since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2014-09-15 OREX Orexigen Therapeutics, Inc. Buy 50,000 4.78 239,100
2014-02-04 CLDN Celladon Corp Buy 62,500 8.00 500,000
2012-07-17 OREX Orexigen Therapeutics, Inc. Option Ex 150,000 1.68 252,000
2012-07-17 OREX Orexigen Therapeutics, Inc. Sale 150,000 7.66 1,149,000
2012-07-13 OREX Orexigen Therapeutics, Inc. Sale 147,100 6.70 985,570
2012-07-12 OREX Orexigen Therapeutics, Inc. Option Ex 2,900 1.66 4,814
2012-07-13 OREX Orexigen Therapeutics, Inc. Option Ex 147,100 1.66 244,186
2012-07-12 OREX Orexigen Therapeutics, Inc. Sale 2,900 6.66 19,314
2012-06-28 OREX Orexigen Therapeutics, Inc. Sale 100,000 5.66 566,000
2012-06-29 OREX Orexigen Therapeutics, Inc. Sale 125,000 6.08 760,000
2012-06-28 OREX Orexigen Therapeutics, Inc. Option Ex 100,000 1.66 166,000
2012-06-29 OREX Orexigen Therapeutics, Inc. Option Ex 125,000 1.66 207,500
2012-05-24 AMAG Advanced Magnetics Inc Buy 2,000 13.55 27,102
2012-05-25 AMAG Advanced Magnetics Inc Buy 5,500 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Narachi Michael (President and CEO of Orexigen Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.